James Hartje's  Instablog

James Hartje
Send Message
My name is James Hartje, President & Founder of Stocks on Wall Street, an investment advisory company providing readers across the globe investment advice, stock picks, and market updates across our various online publications. Our main website is www.StocksonWallStreet.com You can follow both... More
My company:
Stocks on Wall Street
My blog:
Stocks on Wall Street
  • OSUR Has Soared Recently, Time to Cut Your Position in Half 0 comments
    Apr 23, 2011 3:48 AM | about stocks: OSUR

    Back on March 17th, I wrote an article “PRGX & OSUR: Two Cheap Stocks Loaded With Potential” Within the article, I recommended you all to invest in OraSure Technologies (NASDAQ: OSUR) and now looking back I hope you all did.  In that short time (a little over a month) OSUR has continue to beat the market soaring $2.39 a share, a total yield of 37%+, rising from $6.49 to $8.88 per share.

    Originally I had predicted that OSUR would be a great investment as I expected it to yield over 37% and pass the $8 range within 12-months, not less than one.  Like Peter Lynch said, “It’s all about finding the next ten-bagger.”  Well if OSUR continues this run, it would yield 440%+ over the course of a year, well over what a ten-bagger is suppose to net.  For those of you who have no idea what OSUR does, below is a brief explanation about the company and what made them a great investment over the past month.

    OraSure Technologies (OSURdevelops, manufactures and markets oral fluid diagnostic products and specimen collection devices. I always believe OSUR would be a great investment but never would I believe that the stock would appreciate this quickly.  Most of the rise was due to the fact that OSUR has great value to investors because their new product pipeline that they recently launched as its starting to show lots of value and adding strong results helping boost OSUR’s revenue steam. Adding to this investors are still confident that OSUR will continue to gain momentum when some of their new products get FDA approval.  If this happens, profitability will skyrocket making the stock even more attractive to investors. Currently, I would recommend selling half your position of OSUR due to the significant rise recently and allow yourself to play with some of the house’s money.

    The stock still has the potential to go past $10 if all the FDA approvals eventually go through.  The problem is it’s unexpected when the FDA approvals will actually go through so if not the stock could stay at a standstill for a couple months if not longer.  Anyways hope you guys capitalized on the opportunity when I first recommended OSUR, if not make sure to follow through on the next one as I’m hoping there will be manymore ten-baggers to come.

    Don’t be a stranger leave a comment below and let me know what you think or send them to my Twitter. Also remember to sign up for Stocks on Wall Street’s Monthly Newsletter.
    Stocks: OSUR
Back To James Hartje's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • Read my new article Featured on the Front Page of @SeekingAlpha http://seekingalpha.com/a/whd0 $BBG $CHK $EGN $PXD $XOM
    Jun 21, 2013
  • Still think airline stocks haven't performed well the past 2 years? Think again! $ALGT ⇧87% $BA ⇧20% $DAL ⇧105% $LUV ⇧37% $UAL ⇧61% = ⇧311%
    Feb 20, 2013
  • Still think airline stocks haven't performed well the past 2 years? Think again! ALGT ⇧87% BA ⇧20% DAL ⇧105% LUV ⇧37% UAL ⇧61% Total: ⇧311%
    Feb 20, 2013
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.